Stock market graphs don’t have to be a mystery. Here’s how to read stock charts for any company. Many, or all, of the products featured on this page are from our advertising partners who compensate us ...

The song has been streamed over 3 million times in under a month. A song created through artificial intelligence has made history topping a Billboard country music chart, but it has also sent ...

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...

An electrocardiogram and echocardiogram (echo) are both noninvasive imaging tests that look at the functioning of your heart and can help identify heart disease. An electrocardiogram (EKG or ECG) and ...

Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, ...

The rhythm is regular at a rate of 132 beats/min. The QRS complexes are wide (0.16 sec). Although the QRS complexes have a morphology that resembles a right bundle branch block (RBBB), with a tall ...

ECG Challenge: Hyperlipidemia and Irregular Pulse A 48-year-old man with a history of hyperlipidemia has an irregular pulse during a routine check-up. What does the ECG show?

A widow is suing Centerpoint Medical Center in Independence after alleging doctors ignored her husband’s abnormal heart readings before his surgery, where he died after, a lawsuit alleges. Google Maps ...

Researchers at the University of Mississippi have developed technology to detect heart attacks in real time with a high degree of accuracy, and packed it into a chip that could fit in a wearable ...

Early mornings are sacred to me. When I worked as a barista 15 years ago, I would give myself an extra hour to drink my first coffee of the day and read or jot down some writing ideas before I bolted ...

The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the progression of fibrocalcific aortic valve stenosis in phase I and II studies.